It would be of great interest to use the mechanism described by Luo, Li, et al. to check for KRAS-induced lymphangiogenesis in pancreatic cancers harboring other frequent KRAS mutations, such as G12C, G12V, or G12R. This evidence concerns the gene KRAS and familial pancreatic carcinoma.